RGD peptides induce relaxation of pulmonary arteries and airways via β3-integrins

FASEB Journal

Volumn 28, Issue 5, 2014, Pages 2281-2292

  Welschoff, Julia ^a   Matthey, Michaela ^a   Wenzel, Daniela ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Endothelial nitric oxide synthase; Hypoxia; Pulmonary vascular tone

Indexed keywords

AMINO ACID; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; BETA3 INTEGRIN; CELL SURFACE RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; POTASSIUM CHANNEL;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; FORCE; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; IN VIVO STUDY; LUNG ARTERY PRESSURE; LUNG MODEL; LUNG SLICE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; VASODILATATION;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA; PULMONARY VASCULAR TONE;

ANIMALS; ANOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HEART VENTRICLES; INTEGRIN BETA3; LUNG; MICE; NITRIC OXIDE SYNTHASE TYPE III; OLIGOPEPTIDES; PERFUSION; POTASSIUM CHANNELS; PULMONARY ARTERY; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84901005685     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-246348     Document Type: Article

References (52)

1. Wenzel, D., Schmidt, A., Reimann, K., Hescheler, J., Pfitzer, G., Bloch, W., and Fleischmann, B. K. (2006) Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 98, 1203-1211
2. Wenzel, D., Koch, M., Matthey, M., Heinemann, J. C., and Fleischmann, B. K. (2012) Identification of a novel vasoconstrictor peptide specific for the systemic circulation. Hypertension 59, 1256-1262
3. Curtis, T. M., Keown-Longo, P. J., Vincent, P. A., Homan, S. M., Wheatley, E. M., and Saba, T. M. (1995) Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha 5 beta 1, or TNF-alpha exposure. Am. J. Physiol. 269, L248-L260
4. Qiao, R. L., Yan, W., Lum, H., and Malik, A. B. (1995) Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response. Am. J. Physiol. 269, C110-C117
5. Kawaguchi, M., Hosotani, R., Ohishi, S., Fujii, N., Tulachan, S. S., Koizumi, M., Toyoda, E., Masui, T., Nakajima, S., Tsuji, S., Ida, J., Fujimoto, K., Wada, M., Doi, R., and Imamura, M. (2001) A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf-V-) is the potent inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 288, 711-717
6. Matsuno, H., Stassen, J. M., Vermylen, J., and Deckmyn, H. (1994) Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90, 2203-2206
7. Martinez-Lemus, L. A., Wu, X., Wilson, E., Hill, M. A., Davis, G. E., Davis, M. J., and Meininger, G. A. (2003) Integrins as unique receptors for vascular control. J. Vasc. Res. 40, 211-233
8. Mogford, J. E., Davis, G. E., and Meininger, G. A. (1997) RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles. J. Clin. Invest. 100, 1647-1653
9. Chan, W. L., Holstein-Rathlou, N. H., and Yip, K. P. (2001) Integrin mobilizes intracellular Ca(2β) in renal vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 280, C593-C603
10. Hein, T. W., Platts, S. H., Waitkus-Edwards, K. R., Kuo, L., Mousa, S. A., and Meininger, G. A. (2001) Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation. Am. J. Physiol. Heart Circ. Physiol. 281, H2378-H2384
11. Wu, X., Mogford, J. E., Platts, S. H., Davis, G. E., Meininger, G. A., and Davis, M. J. (1998) Modulation of calcium current in arteriolar smooth muscle by alphav beta3 and alpha5 beta1 integrin ligands. J. Cell Biol. 143, 241-252
12. Kawasaki, J., Davis, G. E., and Davis, M. J. (2004) Regulation of Ca2β-dependent K+ current by alphavbeta3 integrin engagement in vascular endothelium. J. Biol. Chem. 279, 12959-12966
13. Umesh, A., Thompson, M. A., Chini, E. N., Yip, K. P., and Sham, J. S. (2006) Integrin ligands mobilize Ca2β from ryanodine receptor-gated stores and lysosome-related acidic organelles in pulmonary arterial smooth muscle cells. J. Biol. Chem. 281, 34312-34323
14. Sheppard, D. (2003) Functions of pulmonary epithelial integrins: from development to disease. Physiol. Rev. 83, 673-686
15. Godecke, A., Decking, U. K., Ding, Z., Hirchenhain, J., Bidmon, H. J., Godecke, S., and Schrader, J. (1998) Coronary hemodynamics in endothelial NO synthase knockout mice. Circ. Res. 82, 186-194
16. Wenzel, D., Knies, R., Matthey, M., Klein, A. M., Welschoff, J., Stolle, V., Sasse, P., Roll, W., Breuer, J., and Fleischmann, B. K. (2009) beta(2)-adrenoceptor antagonist ICI 118,551 decreases pulmonary vascular tone in mice via a G(i/o) protein/nitric oxide-coupled pathway. Hypertension 54, 157-163
17. Wenzel, D., Matthey, M., Bindila, L., Lerner, R., Lutz, B., Zimmer, A., and Fleischmann, B. K. (2013) Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc. Natl. Acad. Sci. U. S. A. 110, 18710-18715
18. Wenzel, D., Rieck, S., Vosen, S., Mykhaylyk, O., Trueck, C., Eberbeck, D., Trahms, L., Zimmermann, K., Pfeifer, A., and Fleischmann, B. K. (2012) Identification of magnetic nanoparticles for combined positioning and lentiviral transduction of endothelial cells. Pharm. Res. 29, 1242-1254
19. Herz, K., Heinemann, J. C., Hesse, M., Ottersbach, A., Geisen, C., Fuegemann, C. J., Roll, W., Fleischmann, B. K., and Wenzel, D. (2012) Live monitoring of small vessels during development and disease using the flt-1 promoter element. Basic Res. Cardiol. 107, 257
20. Malan, D., Wenzel, D., Schmidt, A., Geisen, C., Raible, A., Bolck, B., Fleischmann, B. K., and Bloch, W. (2010) Endothelial beta1 integrins regulate sprouting and network formation during vascular development. Development 137, 993-1002
21. Aumailley, M., Gurrath, M., Muller, G., Calvete, J., Timpl, R., and Kessler, H. (1991) Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 291, 50-54
22. Singh, B., Fu, C., and Bhattacharya, J. (2000) Vascular expression of the alpha(v)beta(3)-integrin in lung and other organs. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L217-L226
23. Ignarro, L. J. (1989) Endothelium-derived nitric oxide: actions and properties. FASEB J. 3, 31-36
24. Platts, S. H., Mogford, J. E., Davis, M. J., and Meininger, G. A. (1998) Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide. Am. J. Physiol. 275, H1449-H1454
25. Konig, P., Dedio, J., Oess, S., Papadakis, T., Fischer, A., Muller-Esterl, W., and Kummer, W. (2005) NOSIP and its interacting protein, eNOS, in the rat trachea and lung. J. Histochem. Cytochem. 53, 155-164
26. Dekkers, B. G., Bos, I. S., Gosens, R., Halayko, A. J., Zaagsma, J., and Meurs, H. (2010) The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. Am. J. Respir. Crit. Care Med. 181, 556-565
27. Levine, D. J. (2006) Diagnosis and management of pulmonary arterial hypertension: Implications for respiratory care. Respir. Care 51, 368-381
28. Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., and Rabinovitch, M. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43, 13S-24S
29. Burgel, P. R. (2011) The role of small airways in obstructive airway diseases. Eur. Respir. Rev. 20, 23-33
30. Mogford, J. E., Davis, G. E., Platts, S. H., and Meininger, G. A. (1996) Vascular smooth muscle alpha v beta 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ. Res. 79, 821-826
31. Lipke, D. W., Soltis, E. E., Fiscus, R. R., Yang, L., Newman, P. S., and Aziz, S. M. (1996) RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings. Regul. Pept. 63, 23-29
32. Pierschbacher, M. D., and Ruoslahti, E. (1987) Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 262, 17294-17298
33. Pfaff, M., Gohring, W., Brown, J. C., and Timpl, R. (1994) Binding of purified collagen receptors (alpha 1 beta 1, alpha 2 beta 1) and RGD-dependent integrins to laminins and laminin fragments. Eur. J. Biochem. 225, 975-984
34. Schwartz, M. A. (1993) Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J. Cell Biol. 120, 1003-1010
35. Bhattacharya, S., Ying, X., Fu, C., Patel, R., Kuebler, W., Greenberg, S., and Bhattacharya, J. (2000) alpha (v) beta(3) integrin induces tyrosine phosphorylation-dependent Ca(2β) influx in pulmonary endothelial cells. Circ. Res. 86, 456-462
36. Diez-Marques, M. L., Ruiz-Torres, M. P., Griera, M., Lopez-Ongil, S., Saura, M., Rodriguez-Puyol, D., and Rodriguez-Puyol, M. (2006) Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells. Cardiovasc. Res. 69, 359-369
37. Nelson, M. T., and Quayle, J. M. (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268, C799-C822
38. DeHart, G. W., Jin, T., McCloskey, D. E., Pegg, A. E., and Sheppard, D. (2008) The alpha9beta1 integrin enhances cell migration by polyamine-mediated modulation of an inwardrectifier potassium channel. Proc. Natl. Acad. Sci. U. S. A. 105, 7188-7193
39. Archer, S., and Michelakis, E. (2002) The mechanism (s) of hypoxic pulmonary vasoconstriction: potassium channels, redox O(2) sensors, and controversies. News Physiol. Sci. 17, 131-137
40. Sweeney, M., and Yuan, J. X. (2000) Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir. Res. 1, 40-48
41. Irvine, J. C., Favaloro, J. L., and Kemp-Harper, B. K. (2003) NOactivates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41, 1301-1307
42. Zhao, Y. J., Wang, J., Rubin, L. J., and Yuan, X. J. (1997) Inhibition of K(V) and K(Ca) channels antagonizes NO-induced relaxation in pulmonary artery. Am. J. Physiol. 272, H904-H912
43. Thirstrup, S. (2000) Control of airway smooth muscle tone. I-electrophysiology and contractile mediators. Respir. Med. 94, 328-336
44. Arcangeli, A., and Becchetti, A. (2006) Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol. 16, 631-639
45. Botney, M. D., Kaiser, L. R., Cooper, J. D., Mecham, R. P., Parghi, D., Roby, J., and Parks, W. C. (1992) Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am. J. Pathol. 140, 357-364
46. Chapman, H. A. (2004) Disorders of lung matrix remodeling. J. Clin. Invest. 113, 148-157
47. Plow, E. F., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. A., and Ginsberg, M. H. (1985) The effect of Arg-Gly-Aspcontaining peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. U. S. A. 82, 8057-8061
48. Tsikaris, V. (2004) The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor. J. Pept. Sci. 10, 589-602
49. Nicosia, R. F., and Bonanno, E. (1991) Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am. J. Pathol. 138, 829-833
50. Buerkle, M. A., Pahernik, S. A., Sutter, A., Jonczyk, A., Messmer, K., and Dellian, M. (2002) Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br. J. Cancer 86, 788-795
51. Borron, P., McCormack, F. X., Elhalwagi, B. M., Chroneos, Z. C., Lewis, J. F., Zhu, S., Wright, J. R., Shepherd, V. L., Possmayer, F., Inchley, K., and Fraher, L. J. (1998) Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. 275, L679-L686
52. Reardon, D. A., Neyns, B., Weller, M., Tonn, J. C., Nabors, L. B., and Stupp, R. (2011) Cilengitide: an RGD pentapeptide alphanubeta3 and alphanubeta5 integrin inhibitor in development for glioblastoma and other malignancies. Future Oncol. 7, 339-354